Compositions and methods for treating fibromyalgia
Embodiments of the invention generally relate to supplements for treating fibromyalgia and symptoms associated with fibromyalgia.
1. A method of treating fibromyalgia and fibromyalgia-associated symptoms in a human in need thereof, comprising:
administering an effective amount of a nutritional supplement to said human, wherein the nutritional supplement consists essentially of:
about 1 mmol L-arginine;
about 1 mmol Oxo-proline;
about 2 mmol L-lysine;
about 1.5 μmol N-acetyl L-cysteine;
about 2 μmol L-glutamine; and
about 125 μg Schizonepta (aerial parts) powder.
2. The method of claim 1 , wherein administering the nutritional supplement comprises orally administering.
3. The method of claim 1 , wherein administering the nutritional supplement comprises administering about 20-50 gms/kg of body weight of the nutritional supplement.
4. The method of claim 1 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.
5. The method of claim 1 , wherein the nutritional supplement is administered once a week or once a month.
6. The method of claim 1 , wherein the nutritional supplement is administered for at least one of following: fatigue, chronic pain, trouble sleeping, morning stiffness, headaches, and problems with thinking and memory.
7. A method of treating fibromyalgia and fibromyalgia-associated symptoms in a human in need thereof, comprising:
administering an effective amount of a nutritional supplement to said human, wherein the nutritional supplement consists essentially of:
3.44 mmol L-arginine;
5.30 mmol Oxo-proline;
8.21 mmol L-lysine;
6.13 μmol N-acetyl L-cysteine;
6.84 μmol L-glutamine; and
0.50 mg Schizonepta (aerial parts) powder.
8. The method of claim 7 , wherein the nutritional supplement consists of 725.50 mg L-arginine HCl; 683.70 mg L-pyroglutamic acid; 1499.30 mg L-lysine HCl; 1.00 mg N-acetyl L-cysteine USP; 1.00 mg L-glutamine; and 0.50 mg Schizonepta (aerial parts) powder.
9. The method of claim 7 , wherein administering the nutritional supplement comprises orally administering the nutritional supplement.
10. The method of claim 7 , wherein administering the nutritional supplement comprises administering about 20-50 gms/kg of body weight of the nutritional supplement.
11. The method of claim 7 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.
12. The method of claim 7 , wherein the nutritional supplement is administered once a week or once a month.
13. The method of claim 7 , wherein the nutritional is administered one to three times daily.
14. The method of claim 7 , wherein the nutritional supplement is administered on an empty stomach.
15. The method of claim 7 , wherein the nutritional supplement is administered for at least one of following: fatigue, chronic pain, trouble sleeping, morning stiffness, headaches, and problems with thinking and memory.